tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

DTIL Stock Latest News

Buy Rating for Precision BioSciences: Promising Clinical Data and Undervaluation Highlight Favorable Risk/Reward Scenario
RatingsBuy Rating for Precision BioSciences: Promising Clinical Data and Undervaluation Highlight Favorable Risk/Reward Scenario
19h ago
DTIL
Encouraging Initial Data for Precision BioSciences’ PBGENE-HBV Supports Positive Analyst Rating and $60 Target Price
PremiumRatings
Encouraging Initial Data for Precision BioSciences’ PBGENE-HBV Supports Positive Analyst Rating and $60 Target Price
2d ago
DTIL
Positive Outlook for Precision BioSciences: Promising Gene-Editing Therapy for Hepatitis B and Strong Financial Position
PremiumRatings
Positive Outlook for Precision BioSciences: Promising Gene-Editing Therapy for Hepatitis B and Strong Financial Position
2d ago
DTIL
Precision BioSciences announces initial results from ELIMINATE-B trial
PremiumThe Fly
Precision BioSciences announces initial results from ELIMINATE-B trial
2d ago
DTIL
MaxCyte enters strategic platform license with TG Therapeutics
PremiumThe Fly
MaxCyte enters strategic platform license with TG Therapeutics
9d ago
DTIL
MXCT
Precision BioSciences’ Cassie Gorsuch, PhD named CSO
PremiumThe FlyPrecision BioSciences’ Cassie Gorsuch, PhD named CSO
23d ago
DTIL
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
DTIL
IGMS
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
Premium
The Fly
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
1M ago
DTIL
Precision BioSciences to present preclinical PBGENE-HBV data
PremiumThe Fly
Precision BioSciences to present preclinical PBGENE-HBV data
3M ago
DTIL
Precision BioSciences reports Q3 EPS ($2.25), consensus ($1.92)
PremiumThe Fly
Precision BioSciences reports Q3 EPS ($2.25), consensus ($1.92)
4M ago
DTIL
Precision Biosciences (DTIL) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Precision Biosciences (DTIL) Q3 Earnings Cheat Sheet
4M ago
DTIL
Precision BioSciences presents preclinical data on ARCUS at ESGCT
PremiumThe Fly
Precision BioSciences presents preclinical data on ARCUS at ESGCT
4M ago
DTIL
Precision BioSciences Advances Gene Editing Trials Globally
PremiumCompany AnnouncementsPrecision BioSciences Advances Gene Editing Trials Globally
4M ago
8K
DTIL
Precision BioSciences receives CTA approval in Moldova for PBGENE-HBV
Premium
The Fly
Precision BioSciences receives CTA approval in Moldova for PBGENE-HBV
4M ago
DTIL
Precision BioSciences submits CTA to start trial for PBGENE -HBV
Premium
The Fly
Precision BioSciences submits CTA to start trial for PBGENE -HBV
5M ago
DTIL
Precision BioSciences submits CTA to start trial for PBGENE -HBV
PremiumThe Fly
Precision BioSciences submits CTA to start trial for PBGENE -HBV
5M ago
DTIL
Three new option listings and eighteen option delistings on September 23rd
PremiumThe Fly
Three new option listings and eighteen option delistings on September 23rd
5M ago
BFI
TPL
Precision BioSciences Reshuffles Clinical Leadership Team
PremiumCompany Announcements
Precision BioSciences Reshuffles Clinical Leadership Team
5M ago
8K
DTIL
Precision BioSciences chief medical officer Alan List to retire
PremiumThe Fly
Precision BioSciences chief medical officer Alan List to retire
5M ago
DTIL
Precision BioSciences Secures Funds, Bolsters Oncology Partnership
PremiumCompany AnnouncementsPrecision BioSciences Secures Funds, Bolsters Oncology Partnership
6M ago
8K
DTIL
Precision BioSciences receives $13M in proceeds from Imugene note
Premium
The Fly
Precision BioSciences receives $13M in proceeds from Imugene note
6M ago
DTIL
Precision BioSciences partner gets FDA clearance for Azercabtagene Zapreleucel
Premium
The Fly
Precision BioSciences partner gets FDA clearance for Azercabtagene Zapreleucel
7M ago
DTIL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >